Market Overview:
The global hyaluronic acid quantitative determination kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for hyaluronic acid products by hospitals and clinics across the globe. Additionally, technological advancements in quantitative determination kits are also propelling the growth of this market. However, stringent regulatory norms for product approvals are restraining the growth of this market to some extent. On the basis of type, chemiluminescence immunoassay is expected to hold a major share in the global hyaluronic acid quantitative determination kit market during 2018-2030 owing to its high accuracy and sensitivity levels as compared with other types of assays such as time-resolved immunoassay (TRIA).
Product Definition:
Hyaluronic acid is a polysaccharide found in the extracellular matrix of connective tissues. It is an important component of articular cartilage and plays a role in the maintenance of joint health. This kit allows for the quantitative determination of hyaluronic acid in biological samples.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the quantitative determination of hyaluronic acid in biological fluids. It utilizes the principle that light interaction with an analyte generates light and electron-emitting paths within a photodiode array, which is then amplified by a transimpedance amplifier to provide an output signal.
Time-resolved Immunoassay:
Time-resolved immunoassay (TRIA) is a technique that measures the amount of hyaluronic acid in a patient's body without having to wait for its metabolization. The method uses antibodies and their binding partners, which are attached to an enzyme or protein that changes color when bound by the antibody. This change in color can be detected using a spectrophotometer within seconds.
Application Insights:
The market is segmented based on the application of hyaluronic acid quantitative determination kit, into hospital and clinic. The hospital segment dominated the market in 2017 owing to a large number of tests that are performed for diagnosis of diseases. For instance, in case of knee injuries or trauma, doctors may perform X-ray and MRI tests to check for breaks or cracks in bones as well as internal injuries. Such factors contribute towards high demand for rapid diagnostic solutions at hospitals resulting in higher share held by this segment during the forecast period.
Clinic applications are expected to witness significant growth over the forecast period due largely to increasing awareness about sports injuries among athletes which often requires surgical intervention with an overnight stay at a medical facility. As such situations require immediate medical attention along with accurate assessment of injury severity, hyaluronic acid quantitation is increasingly being used by clinicians across clinics worldwide which will further boost product demand over the coming years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and availability of technologically advanced products. Moreover, increasing demand for minimally invasive procedures is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population and increasing prevalence of chronic diseases such as cancer & diabetes that necessitate regular check-ups at hospitals & clinics. The hyaluronan assay kits are used for monitoring disease progression or follow-up visits; therefore, an increase in sales volume would indicate increased demand from this region during the forecast period (2018 - 2030).
In addition, growing medical tourism industry due to low healthcare costs coupled with improving healthcare infrastructure will further propel regional growth over the coming years (2018 - 2030).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the benefits offered by these surgeries over traditional open surgery procedures, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. The Hyaluronic Acid Quantitative Determination Kit market is expected to benefit from this trend as more surgeons adopt its use in their practice.
- Growing prevalence of age-related diseases: Age-related diseases are becoming increasingly common due to the aging population worldwide. Diseases such as arthritis, osteoporosis, and macular degeneration are caused by the natural process of aging and can lead to disability or even death in some cases. The Hyaluronic Acid Quantitative Determination Kit market is expected to benefit from this trend as more people seek treatment for these conditions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyaluronic Acid Quantitative Determination Kit Market Research Report
By Type
Chemiluminescence Immunoassay, Time-resolved Immunoassay
By Application
Hospital, Clinic
By Companies
Innodx, Bioscience, BGI, Chivd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
133
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Hyaluronic Acid Quantitative Determination Kit Market Report Segments:
The global Hyaluronic Acid Quantitative Determination Kit market is segmented on the basis of:
Types
Chemiluminescence Immunoassay, Time-resolved Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Innodx
- Bioscience
- BGI
- Chivd
Highlights of The Hyaluronic Acid Quantitative Determination Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemiluminescence Immunoassay
- Time-resolved Immunoassay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyaluronic Acid Quantitative Determination Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Hyaluronic Acid Quantitative Determination Kit is a laboratory instrument that can be used to measure the amount of hyaluronic acid in a sample.
Some of the key players operating in the hyaluronic acid quantitative determination kit market are Innodx, Bioscience, BGI, Chivd.
The hyaluronic acid quantitative determination kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyaluronic Acid Quantitative Determination Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyaluronic Acid Quantitative Determination Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyaluronic Acid Quantitative Determination Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyaluronic Acid Quantitative Determination Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyaluronic Acid Quantitative Determination Kit Market Size & Forecast, 2020-2028
4.5.1 Hyaluronic Acid Quantitative Determination Kit Market Size and Y-o-Y Growth
4.5.2 Hyaluronic Acid Quantitative Determination Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemiluminescence Immunoassay
5.2.2 Time-resolved Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyaluronic Acid Quantitative Determination Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyaluronic Acid Quantitative Determination Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemiluminescence Immunoassay
9.6.2 Time-resolved Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemiluminescence Immunoassay
10.6.2 Time-resolved Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemiluminescence Immunoassay
11.6.2 Time-resolved Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemiluminescence Immunoassay
12.6.2 Time-resolved Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemiluminescence Immunoassay
13.6.2 Time-resolved Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyaluronic Acid Quantitative Determination Kit Market: Competitive Dashboard
14.2 Global Hyaluronic Acid Quantitative Determination Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Innodx
14.3.2 Bioscience
14.3.3 BGI
14.3.4 Chivd
